A simple nonpharmacologic or pharmacologic intervention can decrease isolated systolic hypertension, enhance quality of life and prevent major cardiovascular and cerebrovascular complications.
Isolated systolic hypertension is a distinct disease entity associated with serious morbidity and mortality, in particular, stroke. The mechanism of systolic hypertension appears to be a reduction in arterial compliance. Identification of patients at greatest risk is paramount. A simple nonpharmacologic or pharmacologic intervention can decrease isolated systolic hypertension, enhance quality of life and prevent major cardiovascular and cerebrovascular complications.